OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a global clinical CRO with 26 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical device studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceuticals, and food supplement studies. Our qualified, fully trained, and dedicated staff have managed more than 1500 studies. OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high-quality project execution, with global coverage. Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas, including oncology, cardiology, dermatology, endocrinology, gastroenterology, gene therapy, hematology, genetic diseases, hepatology, immunology, infectious diseases, musculoskeletal, dietary supplements, metabolism and nutrition disorders, nephrology, neurology, onco-hematology, ophthalmology, respiratory diseases, rare diseases, urogenital disorders and vaccines. OPIS is committed to continuous growth and expansion, and currently we have affiliates in 18 countries around the world. For more information, visit www.opisresearch.com For Employment and Careers, visit www.opisresearch.com/opis-career/
